S 2067 114th Congress Senate

EUREKA Act

Official title: A bill to establish EUREKA Prize Competitions to accelerate discovery and development of disease-modifying, preventive, or curative treatments for Alzheimer's disease and related dementia, to encourage efforts to enhance detection and diagnosis of such diseases, or to enhance the quality and efficiency of care of individuals with such diseases.

Introduced: September 24, 2015 Introduced by: Wicker, Roger F. Republican · Mississippi See on congress.gov

Health Advisory bodiesAgingDepartment of Health and Human ServicesHealth programs administration and funding

More subjectsShow fewer subjects

Health promotion and preventive careHealth technology, devices, suppliesMedical researchMedical tests and diagnostic methodsNational Institutes of Health (NIH)Neurological disordersResearch administration and funding

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Sep 22, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6895-6896)

Sep 22, 2015

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action September 22, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6895-6896)

Plain-English summary Congressional Research Service

Ensuring Useful Research Expenditures is Key for Alzheimer's Act or the EUREKA Act

This bill amends the Public Health Service Act to require the National Institutes of Health (NIH) to establish EUREKA prize competitions to achieve high-priority breakthroughs in Alzheimer's disease and dementia prevention, diagnosis, treatment, and care.

The NIH must: (1) convene an advisory council of nongovernmental experts in Alzheimer's disease and dementia to develop the EUREKA prize competitions, and (2) appoint a panel of judges to evaluate submissions. The council and panel are not subject to the Federal Advisory Committee Act.

Support for EUREKA prize competitions may be provided by private organizations and individuals.

Related & companion bills 1

Bill text 1 version